SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-036060
Filing Date
2024-09-12
Accepted
2024-09-12 16:45:37
Documents
16
Period of Report
2024-09-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41884
2 ex10-1.htm EX-10.1 16341
3 ex10-2.htm EX-10.2 15190
  Complete submission text file 0001493152-24-036060.txt   253892

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20240911.xsd EX-101.SCH 3015
5 XBRL LABEL FILE aim-20240911_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE aim-20240911_pre.xml EX-101.PRE 24166
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3567
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 241295494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)